By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Good Start Genetics today announced the initial closing of a Series B Preferred Stock financing that raised $14 million.

The funds will be used to support commercialization efforts of the Cambridge, Mass.-based firm's screening tests and to support R&D work to develop its proprietary platform technology for future applications, it said.

Existing investors OrbiMed Advisors, Safeguard Scientifics, and SV Life Sciences led the financing round.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.